ARGENX SE's ticker is ARGX and the CUSIP is 04016X101. A total of 253 filers reported holding ARGENX SE in Q3 2022. The put-call ratio across all filers is 1.12 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,168,580 | +163.5% | 4,411 | +108.9% | 0.00% | +300.0% |
| Q2 2023 | $823,110 | +48.3% | 2,112 | +41.7% | 0.00% | 0.0% |
| Q1 2023 | $555,144 | +10.1% | 1,490 | +11.9% | 0.00% | 0.0% |
| Q4 2022 | $504,223 | +23.3% | 1,331 | +14.9% | 0.00% | 0.0% |
| Q3 2022 | $409,000 | +65.6% | 1,158 | +77.3% | 0.00% | – |
| Q2 2022 | $247,000 | -60.2% | 653 | -71.0% | 0.00% | -100.0% |
| Q1 2021 | $620,000 | +0.6% | 2,250 | +7.4% | 0.00% | 0.0% |
| Q4 2020 | $616,000 | +15.4% | 2,095 | +3.1% | 0.00% | 0.0% |
| Q3 2020 | $534,000 | +17.6% | 2,032 | +0.6% | 0.00% | 0.0% |
| Q2 2020 | $454,000 | +87.6% | 2,019 | +9.7% | 0.00% | 0.0% |
| Q1 2020 | $242,000 | -19.9% | 1,841 | -2.1% | 0.00% | 0.0% |
| Q4 2019 | $302,000 | – | 1,880 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SAL Trading, LLC | 36,100 | $17,747,843 | 24.88% |
| Artia Global Partners LP | 49,238 | $24,206,878 | 10.06% |
| Paradigm Biocapital Advisors LP | 261,443 | $128,533,222 | 8.72% |
| Darwin Global Management, Ltd. | 45,615 | $22,425,702 | 7.89% |
| Avoro Capital Advisors LLC | 1,000,000 | $491,630,000 | 7.67% |
| Bellevue Group AG | 911,530 | $448,135,494 | 7.22% |
| Eagle Health Investments LP | 64,400 | $31,660,972 | 6.98% |
| DCF Advisers, LLC | 22,000 | $10,815,860 | 5.89% |
| SAL Trading, LLC | 8,149 | $4,006,293 | 5.62% |
| RTW INVESTMENTS, LP | 507,195 | $249,352,278 | 5.26% |